Contact
Please use this form to send email to PR contact of this press release:
Hugel resubmits BLA for its botulinum toxin, Botulax to the U.S. FDA
TO:
Please use this form to send email to PR contact of this press release:
Hugel resubmits BLA for its botulinum toxin, Botulax to the U.S. FDA
TO: